185 related articles for article (PubMed ID: 33621806)
1. Using ICD-10-CM codes to detect illicit substance use: A comparison with retrospective self-report.
Rowe CL; Santos GM; Kornbluh W; Bhardwaj S; Faul M; Coffin PO
Drug Alcohol Depend; 2021 Apr; 221():108537. PubMed ID: 33621806
[TBL] [Abstract][Full Text] [Related]
2. Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department.
Rowe C; Vittinghoff E; Santos GM; Behar E; Turner C; Coffin PO
Acad Emerg Med; 2017 Apr; 24(4):475-483. PubMed ID: 27763703
[TBL] [Abstract][Full Text] [Related]
3. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
Shearer RD; Jones A; Howell BA; Segel JE; Winkelman TNA
J Subst Abuse Treat; 2022 Dec; 143():108894. PubMed ID: 36206585
[TBL] [Abstract][Full Text] [Related]
4. Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain.
Coffin PO; Rowe C; Oman N; Sinchek K; Santos GM; Faul M; Bagnulo R; Mohamed D; Vittinghoff E
PLoS One; 2020; 15(5):e0232538. PubMed ID: 32365132
[TBL] [Abstract][Full Text] [Related]
5. Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department.
Ali SA; Shell J; Harris R; Bedder M
Harm Reduct J; 2023 Oct; 20(1):144. PubMed ID: 37798673
[TBL] [Abstract][Full Text] [Related]
6. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.
Guevara MG; LaRue L; Zacharoff KL; Whitley P; Dawson E; Passik SD
J Opioid Manag; 2022; 18(4):361-375. PubMed ID: 36052933
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020.
Whitley P; LaRue L; Fernandez SA; Passik SD; Dawson E; Jackson RD
JAMA Netw Open; 2022 Jun; 5(6):e2215425. PubMed ID: 35657623
[TBL] [Abstract][Full Text] [Related]
8. Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study.
Karamouzian M; Buxton JA; Hategeka C; Nosova E; Hayashi K; Milloy MJ; Kerr T
Int J Drug Policy; 2022 Nov; 109():103852. PubMed ID: 36122483
[TBL] [Abstract][Full Text] [Related]
9. Disparities in Use/Misuse of Specific Illicit and Prescription Drugs among Sexual Minority Adults in a National Sample.
Schuler MS; Collins RL; Ramchand R
Subst Use Misuse; 2022; 57(3):461-471. PubMed ID: 35067155
[No Abstract] [Full Text] [Related]
10. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
[TBL] [Abstract][Full Text] [Related]
11. Illicit Substance Use in US Adults With Chronic Low Back Pain.
Shmagel A; Krebs E; Ensrud K; Foley R
Spine (Phila Pa 1976); 2016 Sep; 41(17):1372-1377. PubMed ID: 27438382
[TBL] [Abstract][Full Text] [Related]
12. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017.
Goyal S; Saunders KC; Moore CS; Fillo KT; Ko JY; Manning SE; Shapiro-Mendoza C; Gupta M; Romero L; Coy KC; McDow KB; Keaton AA; Sinatra J; Jones K; Alpren C; Barfield WD; Diop H
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):951-955. PubMed ID: 32701936
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study.
Qeadan F; Madden EF; Mensah NA; Tingey B; Herron J; Hernandez-Vallant A; Venner KL; English K; Dixit A
BMJ Open; 2022 May; 12(5):e053686. PubMed ID: 35501103
[TBL] [Abstract][Full Text] [Related]
14. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.
Beliveau CM; McMahan VM; Arenander J; Angst MS; Kushel M; Torres A; Santos GM; Coffin PO
Subst Abus; 2022; 43(1):179-186. PubMed ID: 33798030
[TBL] [Abstract][Full Text] [Related]
15. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
Faller RW; Erausquin JT; McCoy TP
Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
[No Abstract] [Full Text] [Related]
16. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety.
Saloner B; Whitley P; Dawson E; Passik S; Gordon AJ; Stein BD
Addiction; 2023 Aug; 118(8):1549-1556. PubMed ID: 37158468
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
[TBL] [Abstract][Full Text] [Related]
18. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity, specificity and predictive values of ICD-10 substance use codes in a cohort of substance use-related endocarditis patients.
Campanile Y; Silverman M
Am J Drug Alcohol Abuse; 2022 Sep; 48(5):538-547. PubMed ID: 35579599
[No Abstract] [Full Text] [Related]
20. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
Hoots B; Vivolo-Kantor A; Seth P
Addiction; 2020 May; 115(5):946-958. PubMed ID: 31912625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
